Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VRTX | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | $26.8M | -$5.8M | -17.8% | Jun 5, 2024 |
EIGRQ | Eiger BioPharmaceuticals, Inc. | Director | Mar 1, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|